Next Article in Journal
Quercetin-Based Nanocomposites as a Tool to Improve Dental Disease Management
Next Article in Special Issue
Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives
Previous Article in Journal
Effects of Antibiotics upon the Gut Microbiome: A Review of the Literature
Review

Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
*
Author to whom correspondence should be addressed.
Biomedicines 2020, 8(11), 503; https://doi.org/10.3390/biomedicines8110503
Received: 2 November 2020 / Revised: 12 November 2020 / Accepted: 14 November 2020 / Published: 16 November 2020
(This article belongs to the Special Issue Experimental and Translational Research on Liver Disease)
Heparan sulfate is a highly sulfated polysaccharide abundant on the surface of hepatocytes and surrounding extracellular matrix. Emerging evidence demonstrates that heparan sulfate plays an important role in neutralizing the activities of proinflammatory damage associate molecular patterns (DAMPs) that are released from hepatocytes under pathological conditions. Unlike proteins and nucleic acids, isolation of homogenous heparan sulfate polysaccharides from biological sources is not possible, adding difficulty to study the functional role of heparan sulfate. Recent advancement in the development of a chemoenzymatic approach allows production of a large number of structurally defined oligosaccharides. These oligosaccharides are used to probe the physiological functions of heparan sulfate in liver damage under different pathological conditions. The findings provide a potential new therapeutic agent to treat liver diseases that are associated with excessive inflammation. View Full-Text
Keywords: heparan sulfate; chemoenzymatic synthesis; oligosaccharides; DAMPS; inflammation heparan sulfate; chemoenzymatic synthesis; oligosaccharides; DAMPS; inflammation
Show Figures

Figure 1

MDPI and ACS Style

Arnold, K.; Liao, Y.-E.; Liu, J. Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage. Biomedicines 2020, 8, 503. https://doi.org/10.3390/biomedicines8110503

AMA Style

Arnold K, Liao Y-E, Liu J. Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage. Biomedicines. 2020; 8(11):503. https://doi.org/10.3390/biomedicines8110503

Chicago/Turabian Style

Arnold, Katelyn, Yi-En Liao, and Jian Liu. 2020. "Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage" Biomedicines 8, no. 11: 503. https://doi.org/10.3390/biomedicines8110503

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop